Christopher James Gibson, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Dioxygenases | 7 | 2024 | 316 | 1.340 |
Why?
|
Hematopoiesis | 12 | 2023 | 2072 | 1.310 |
Why?
|
Hematopoietic Stem Cell Transplantation | 10 | 2024 | 5442 | 1.290 |
Why?
|
Hematologic Neoplasms | 6 | 2021 | 1832 | 1.070 |
Why?
|
Leukemia, Myeloid, Acute | 9 | 2022 | 3523 | 0.860 |
Why?
|
Myelodysplastic Syndromes | 7 | 2023 | 1352 | 0.850 |
Why?
|
Leukemia, Myelomonocytic, Chronic | 1 | 2023 | 97 | 0.810 |
Why?
|
Clone Cells | 3 | 2017 | 1692 | 0.600 |
Why?
|
Contusions | 1 | 2016 | 81 | 0.540 |
Why?
|
Factor VIII | 1 | 2016 | 347 | 0.470 |
Why?
|
Lymphoma, Non-Hodgkin | 2 | 2021 | 1381 | 0.460 |
Why?
|
Thrombophlebitis | 1 | 2014 | 309 | 0.450 |
Why?
|
Hematologic Diseases | 1 | 2017 | 498 | 0.440 |
Why?
|
Hemophilia A | 1 | 2016 | 351 | 0.440 |
Why?
|
Neoplasms, Second Primary | 2 | 2020 | 1061 | 0.440 |
Why?
|
Mutation | 24 | 2024 | 29786 | 0.430 |
Why?
|
Hematopoietic Stem Cells | 4 | 2021 | 3386 | 0.360 |
Why?
|
Transplantation Conditioning | 5 | 2022 | 1598 | 0.360 |
Why?
|
DNA-Binding Proteins | 7 | 2024 | 9648 | 0.360 |
Why?
|
Dyslexia | 2 | 2012 | 248 | 0.350 |
Why?
|
Transplantation, Homologous | 5 | 2023 | 4776 | 0.340 |
Why?
|
Neutropenia | 1 | 2014 | 895 | 0.330 |
Why?
|
Hodgkin Disease | 1 | 2017 | 1415 | 0.330 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2015 | 1434 | 0.330 |
Why?
|
Neoplasm Proteins | 2 | 2018 | 3703 | 0.320 |
Why?
|
Tumor Suppressor Protein p53 | 5 | 2023 | 2948 | 0.300 |
Why?
|
Transplantation, Autologous | 3 | 2024 | 2124 | 0.300 |
Why?
|
Language Disorders | 1 | 2008 | 141 | 0.290 |
Why?
|
Myeloproliferative Disorders | 2 | 2024 | 606 | 0.290 |
Why?
|
Leukemia | 3 | 2022 | 1511 | 0.290 |
Why?
|
Lymphohistiocytosis, Hemophagocytic | 2 | 2020 | 260 | 0.290 |
Why?
|
Stomach Neoplasms | 1 | 2014 | 1333 | 0.250 |
Why?
|
Molecular Targeted Therapy | 1 | 2015 | 2727 | 0.240 |
Why?
|
Environment Design | 1 | 2005 | 178 | 0.230 |
Why?
|
Ambulatory Care | 1 | 2014 | 2708 | 0.220 |
Why?
|
Breast Neoplasms | 3 | 2023 | 20822 | 0.200 |
Why?
|
Hepatitis | 1 | 2023 | 227 | 0.190 |
Why?
|
Hydroxyurea | 1 | 2022 | 290 | 0.190 |
Why?
|
Humans | 55 | 2024 | 744343 | 0.190 |
Why?
|
Splenic Neoplasms | 1 | 2021 | 100 | 0.190 |
Why?
|
Survival Rate | 6 | 2021 | 12788 | 0.180 |
Why?
|
Recurrence | 2 | 2022 | 8340 | 0.180 |
Why?
|
Giant Cell Arteritis | 1 | 2024 | 292 | 0.180 |
Why?
|
Myeloid-Lymphoid Leukemia Protein | 1 | 2022 | 294 | 0.180 |
Why?
|
Chromosome Mapping | 1 | 2008 | 4740 | 0.170 |
Why?
|
Tandem Repeat Sequences | 1 | 2020 | 185 | 0.170 |
Why?
|
Lymphoma, B-Cell, Marginal Zone | 1 | 2021 | 180 | 0.170 |
Why?
|
Apoptosis | 1 | 2015 | 9727 | 0.170 |
Why?
|
Workplace | 1 | 2005 | 836 | 0.170 |
Why?
|
Chromosomes, Human, Pair 6 | 2 | 2012 | 380 | 0.170 |
Why?
|
Aging, Premature | 1 | 2019 | 47 | 0.170 |
Why?
|
Occupational Health | 1 | 2005 | 809 | 0.170 |
Why?
|
Walking | 1 | 2005 | 1180 | 0.160 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2022 | 670 | 0.160 |
Why?
|
Aged | 17 | 2023 | 163280 | 0.160 |
Why?
|
Neoplasm, Residual | 1 | 2022 | 973 | 0.150 |
Why?
|
Chromosome Aberrations | 3 | 2021 | 1813 | 0.150 |
Why?
|
Encephalitis, Varicella Zoster | 1 | 2016 | 9 | 0.140 |
Why?
|
Leukopenia | 1 | 2017 | 212 | 0.140 |
Why?
|
fms-Like Tyrosine Kinase 3 | 1 | 2020 | 491 | 0.140 |
Why?
|
Lupus Coagulation Inhibitor | 1 | 2016 | 31 | 0.140 |
Why?
|
Middle Aged | 22 | 2023 | 213383 | 0.140 |
Why?
|
Proto-Oncogene Proteins | 5 | 2022 | 4554 | 0.140 |
Why?
|
Telomerase | 1 | 2021 | 730 | 0.140 |
Why?
|
Adenocarcinoma | 1 | 2014 | 6364 | 0.140 |
Why?
|
Leukemia, Hairy Cell | 1 | 2016 | 82 | 0.140 |
Why?
|
Alleles | 3 | 2022 | 6933 | 0.140 |
Why?
|
Disease Susceptibility | 1 | 2023 | 1782 | 0.140 |
Why?
|
Nuclear Proteins | 3 | 2018 | 5853 | 0.140 |
Why?
|
Adult | 20 | 2023 | 214055 | 0.130 |
Why?
|
Gout | 1 | 2022 | 573 | 0.130 |
Why?
|
Partial Thromboplastin Time | 1 | 2016 | 206 | 0.130 |
Why?
|
Acyclovir | 1 | 2016 | 272 | 0.130 |
Why?
|
Motor Activity | 1 | 2005 | 2714 | 0.130 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2020 | 719 | 0.130 |
Why?
|
Core Binding Factor Alpha 2 Subunit | 1 | 2017 | 345 | 0.130 |
Why?
|
Gene Frequency | 2 | 2020 | 3588 | 0.120 |
Why?
|
Telomere | 1 | 2020 | 910 | 0.120 |
Why?
|
Stem Cell Transplantation | 2 | 2020 | 1620 | 0.120 |
Why?
|
MAP Kinase Kinase 1 | 1 | 2016 | 337 | 0.120 |
Why?
|
Gene Expression Regulation, Leukemic | 1 | 2018 | 651 | 0.120 |
Why?
|
Female | 24 | 2023 | 380194 | 0.120 |
Why?
|
Blood Coagulation Factors | 1 | 2016 | 355 | 0.120 |
Why?
|
Blister | 1 | 2014 | 86 | 0.120 |
Why?
|
DNA Damage | 1 | 2023 | 2432 | 0.120 |
Why?
|
Health Promotion | 1 | 2005 | 2205 | 0.110 |
Why?
|
Medical Informatics | 1 | 2020 | 745 | 0.110 |
Why?
|
Liver Cirrhosis | 1 | 2023 | 1863 | 0.110 |
Why?
|
International Normalized Ratio | 1 | 2014 | 367 | 0.110 |
Why?
|
Platelet Count | 1 | 2015 | 781 | 0.110 |
Why?
|
Albumins | 1 | 2015 | 569 | 0.100 |
Why?
|
Ferritins | 1 | 2015 | 590 | 0.100 |
Why?
|
Genetic Variation | 2 | 2021 | 6544 | 0.100 |
Why?
|
Bone Marrow | 2 | 2023 | 2948 | 0.100 |
Why?
|
Osteoporosis | 1 | 2021 | 1580 | 0.100 |
Why?
|
Disease Progression | 3 | 2023 | 13284 | 0.100 |
Why?
|
Young Adult | 9 | 2021 | 56430 | 0.100 |
Why?
|
Lymphoma | 1 | 2021 | 1877 | 0.100 |
Why?
|
Sequence Analysis, DNA | 3 | 2018 | 4803 | 0.100 |
Why?
|
Diagnosis, Differential | 3 | 2016 | 12959 | 0.100 |
Why?
|
Male | 21 | 2022 | 350118 | 0.100 |
Why?
|
Thrombophilia | 1 | 2014 | 305 | 0.100 |
Why?
|
Adolescent | 8 | 2021 | 85781 | 0.100 |
Why?
|
Genetic Markers | 1 | 2017 | 2634 | 0.090 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2020 | 3597 | 0.090 |
Why?
|
Repressor Proteins | 2 | 2022 | 3023 | 0.090 |
Why?
|
Edema | 1 | 2014 | 789 | 0.090 |
Why?
|
Leukocytes | 1 | 2018 | 2043 | 0.090 |
Why?
|
Postpartum Period | 1 | 2016 | 1086 | 0.090 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2021 | 1596 | 0.090 |
Why?
|
Stomach | 1 | 2014 | 697 | 0.090 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 2 | 2022 | 3047 | 0.090 |
Why?
|
Chronic Disease | 2 | 2021 | 9146 | 0.090 |
Why?
|
Graft vs Host Disease | 1 | 2021 | 2957 | 0.080 |
Why?
|
Leg | 1 | 2014 | 1116 | 0.080 |
Why?
|
Disease-Free Survival | 4 | 2021 | 6895 | 0.080 |
Why?
|
Reading | 1 | 2012 | 558 | 0.080 |
Why?
|
Inflammasomes | 2 | 2023 | 495 | 0.080 |
Why?
|
DNA Mutational Analysis | 1 | 2017 | 4186 | 0.080 |
Why?
|
Autoantibodies | 1 | 2016 | 2035 | 0.080 |
Why?
|
Chromosomes, Human, Pair 13 | 1 | 2008 | 197 | 0.080 |
Why?
|
Tissue Donors | 1 | 2017 | 2240 | 0.080 |
Why?
|
Chromosomes, Human, Pair 7 | 1 | 2008 | 322 | 0.070 |
Why?
|
Genome, Human | 1 | 2020 | 4420 | 0.070 |
Why?
|
Nerve Tissue Proteins | 2 | 2012 | 4462 | 0.070 |
Why?
|
Mutation, Missense | 1 | 2016 | 2564 | 0.070 |
Why?
|
Chromosomes, Human, Pair 15 | 1 | 2008 | 373 | 0.070 |
Why?
|
Mice | 9 | 2023 | 81183 | 0.070 |
Why?
|
Stem Cells | 1 | 2020 | 3567 | 0.070 |
Why?
|
Cytokines | 1 | 2021 | 7322 | 0.070 |
Why?
|
Graft Survival | 1 | 2017 | 3737 | 0.070 |
Why?
|
Recombinant Proteins | 1 | 2016 | 6622 | 0.070 |
Why?
|
Sulfonamides | 1 | 2015 | 1938 | 0.070 |
Why?
|
Karyotyping | 1 | 2008 | 1243 | 0.070 |
Why?
|
Endothelium, Vascular | 1 | 2018 | 4456 | 0.070 |
Why?
|
Infant | 3 | 2021 | 35136 | 0.060 |
Why?
|
Ischemia | 1 | 2014 | 1907 | 0.060 |
Why?
|
Government Agencies | 1 | 2005 | 156 | 0.060 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2023 | 9239 | 0.060 |
Why?
|
Venous Thrombosis | 1 | 2014 | 1239 | 0.060 |
Why?
|
Child, Preschool | 3 | 2021 | 41006 | 0.060 |
Why?
|
Immunoglobulin G | 1 | 2016 | 4560 | 0.060 |
Why?
|
Medical Audit | 1 | 2005 | 467 | 0.060 |
Why?
|
Retrospective Studies | 7 | 2023 | 77449 | 0.060 |
Why?
|
Aged, 80 and over | 6 | 2020 | 57776 | 0.060 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2016 | 2104 | 0.060 |
Why?
|
Neoplasms | 3 | 2022 | 21683 | 0.060 |
Why?
|
Child | 6 | 2021 | 77709 | 0.060 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2022 | 11524 | 0.060 |
Why?
|
Models, Biological | 2 | 2020 | 9583 | 0.050 |
Why?
|
Risk Factors | 6 | 2023 | 72290 | 0.050 |
Why?
|
Microtubule-Associated Proteins | 1 | 2008 | 1086 | 0.050 |
Why?
|
Mitochondria | 1 | 2015 | 3520 | 0.050 |
Why?
|
Coronary Disease | 1 | 2017 | 6077 | 0.050 |
Why?
|
Allosteric Site | 1 | 2022 | 103 | 0.050 |
Why?
|
Multiple Myeloma | 1 | 2020 | 5181 | 0.050 |
Why?
|
Cytoskeletal Proteins | 1 | 2008 | 1364 | 0.050 |
Why?
|
Phosphoric Monoester Hydrolases | 1 | 2023 | 431 | 0.050 |
Why?
|
Receptors, Immunologic | 1 | 2008 | 1423 | 0.050 |
Why?
|
Animals | 9 | 2023 | 168757 | 0.050 |
Why?
|
World Health Organization | 2 | 2018 | 1318 | 0.050 |
Why?
|
Genetic Predisposition to Disease | 2 | 2020 | 17446 | 0.050 |
Why?
|
Gene Duplication | 1 | 2022 | 329 | 0.050 |
Why?
|
Atherosclerosis | 1 | 2017 | 3445 | 0.050 |
Why?
|
alpha Karyopherins | 1 | 2020 | 41 | 0.050 |
Why?
|
Eukaryotic Initiation Factors | 1 | 2021 | 92 | 0.050 |
Why?
|
Blood Cell Count | 1 | 2021 | 403 | 0.050 |
Why?
|
Forkhead Transcription Factors | 1 | 2008 | 1613 | 0.050 |
Why?
|
Alendronate | 1 | 2021 | 171 | 0.050 |
Why?
|
Dipeptides | 1 | 2022 | 409 | 0.050 |
Why?
|
Survival Analysis | 3 | 2018 | 10252 | 0.040 |
Why?
|
Time Factors | 1 | 2021 | 40075 | 0.040 |
Why?
|
Odds Ratio | 2 | 2023 | 9849 | 0.040 |
Why?
|
Algorithms | 1 | 2020 | 13881 | 0.040 |
Why?
|
Toll-Like Receptor 9 | 1 | 2020 | 212 | 0.040 |
Why?
|
Epigenesis, Genetic | 2 | 2023 | 3647 | 0.040 |
Why?
|
Genetic Fitness | 1 | 2020 | 121 | 0.040 |
Why?
|
Carboplatin | 1 | 2022 | 801 | 0.040 |
Why?
|
Adenosine Triphosphatases | 1 | 2023 | 839 | 0.040 |
Why?
|
National Heart, Lung, and Blood Institute (U.S.) | 1 | 2020 | 314 | 0.040 |
Why?
|
Melphalan | 1 | 2020 | 431 | 0.040 |
Why?
|
Bone Marrow Diseases | 1 | 2021 | 231 | 0.040 |
Why?
|
Prospective Studies | 1 | 2023 | 53288 | 0.040 |
Why?
|
Africa | 1 | 2020 | 673 | 0.040 |
Why?
|
Aminopyridines | 1 | 2022 | 542 | 0.040 |
Why?
|
Serine | 1 | 2022 | 826 | 0.040 |
Why?
|
Cell Cycle Proteins | 2 | 2022 | 3462 | 0.040 |
Why?
|
Interferon-alpha | 1 | 2022 | 895 | 0.040 |
Why?
|
Ribosomes | 1 | 2021 | 500 | 0.040 |
Why?
|
Cardiovascular Diseases | 1 | 2023 | 15165 | 0.040 |
Why?
|
Osteoclasts | 1 | 2021 | 729 | 0.040 |
Why?
|
Mice, Mutant Strains | 1 | 2020 | 1866 | 0.040 |
Why?
|
Leukemia, Myeloid | 1 | 2020 | 707 | 0.040 |
Why?
|
Signal Transduction | 2 | 2022 | 23403 | 0.040 |
Why?
|
Prognosis | 4 | 2023 | 29063 | 0.040 |
Why?
|
Interleukins | 1 | 2021 | 791 | 0.040 |
Why?
|
Interleukin-1beta | 1 | 2022 | 972 | 0.040 |
Why?
|
Uric Acid | 1 | 2022 | 766 | 0.040 |
Why?
|
Cyclophosphamide | 1 | 2022 | 2242 | 0.040 |
Why?
|
Structure-Activity Relationship | 1 | 2022 | 3129 | 0.040 |
Why?
|
Lethargy | 1 | 2016 | 39 | 0.040 |
Why?
|
Germ Cells | 1 | 2020 | 631 | 0.030 |
Why?
|
Selection, Genetic | 1 | 2020 | 914 | 0.030 |
Why?
|
Cell Cycle | 1 | 2023 | 2967 | 0.030 |
Why?
|
Paclitaxel | 1 | 2022 | 1708 | 0.030 |
Why?
|
Validation Studies as Topic | 1 | 2015 | 159 | 0.030 |
Why?
|
Mice, Knockout | 2 | 2021 | 14557 | 0.030 |
Why?
|
Exons | 1 | 2020 | 2437 | 0.030 |
Why?
|
Protein Conformation | 1 | 2022 | 4011 | 0.030 |
Why?
|
DNA Repair | 1 | 2023 | 2046 | 0.030 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2022 | 3479 | 0.030 |
Why?
|
Review Literature as Topic | 1 | 2016 | 336 | 0.030 |
Why?
|
Age of Onset | 1 | 2020 | 3271 | 0.030 |
Why?
|
Tachycardia | 1 | 2016 | 619 | 0.030 |
Why?
|
Megakaryocytes | 1 | 2018 | 545 | 0.030 |
Why?
|
Inflammation | 2 | 2023 | 10638 | 0.030 |
Why?
|
Pleural Effusion | 1 | 2016 | 338 | 0.030 |
Why?
|
Myeloid Cells | 1 | 2018 | 810 | 0.030 |
Why?
|
Immunotherapy, Adoptive | 1 | 2021 | 1270 | 0.030 |
Why?
|
Germ-Line Mutation | 1 | 2020 | 1788 | 0.030 |
Why?
|
Chromosomal Proteins, Non-Histone | 1 | 2018 | 736 | 0.030 |
Why?
|
Alanine Transaminase | 1 | 2015 | 592 | 0.030 |
Why?
|
RNA | 1 | 2022 | 2749 | 0.030 |
Why?
|
Health Status | 1 | 2005 | 4034 | 0.030 |
Why?
|
Antibodies, Neutralizing | 1 | 2021 | 1978 | 0.030 |
Why?
|
Carbon Monoxide | 1 | 2015 | 531 | 0.030 |
Why?
|
Prednisone | 1 | 2016 | 1574 | 0.020 |
Why?
|
Infusions, Intravenous | 1 | 2016 | 2274 | 0.020 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2020 | 2942 | 0.020 |
Why?
|
Chromatin | 1 | 2022 | 2934 | 0.020 |
Why?
|
Heart Failure | 1 | 2014 | 10900 | 0.020 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2020 | 2915 | 0.020 |
Why?
|
Pilot Projects | 1 | 2022 | 8324 | 0.020 |
Why?
|
Creatinine | 1 | 2015 | 1919 | 0.020 |
Why?
|
Comorbidity | 2 | 2015 | 10388 | 0.020 |
Why?
|
Dyspnea | 1 | 2016 | 1303 | 0.020 |
Why?
|
Cohort Studies | 2 | 2020 | 40561 | 0.020 |
Why?
|
Genomics | 1 | 2022 | 5720 | 0.020 |
Why?
|
Brain | 1 | 2012 | 26385 | 0.020 |
Why?
|
United States | 2 | 2020 | 69872 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2020 | 14722 | 0.020 |
Why?
|
Smoking | 1 | 2022 | 8987 | 0.020 |
Why?
|
Risk | 1 | 2017 | 9687 | 0.020 |
Why?
|
Predictive Value of Tests | 1 | 2020 | 15076 | 0.020 |
Why?
|
Cell Differentiation | 1 | 2021 | 11483 | 0.010 |
Why?
|
Immunosuppressive Agents | 1 | 2016 | 4149 | 0.010 |
Why?
|
Phenotype | 1 | 2020 | 16365 | 0.010 |
Why?
|
Electrocardiography | 1 | 2016 | 6442 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2020 | 25625 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2017 | 21746 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2020 | 13695 | 0.010 |
Why?
|
Brain Mapping | 1 | 2012 | 6669 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2018 | 63114 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2012 | 39050 | 0.010 |
Why?
|